Cardiometabolic Disorders News

Researchers found evidence that GLP-1 receptor agonists, but not SGLT2 inhibitors or DPP-IV inhibitors, may help prevent stroke for individuals with type 2 diabetes, according to results of a meta-analysis.

The odds of undergoing a successful pancreas transplantation for people with diabetes have increased in recent years, but the number of adults undergoing the procedure is declining, according to a review article.

High lipoprotein(a) measured during childhood was predictive of atherosclerotic CVD development during adulthood, according to an analysis of two cohorts published in Circulation.

Nearly half of a cohort of adults with type 2 diabetes participating in a calorie-restricted intermittent fasting intervention achieved diabetes remission, according to findings from a randomized controlled trial in China.

An analysis of 13 randomized controlled trials of SGLT2 inhibitors showed the class reduced CV death, HF hospitalization and serious adverse events in people with HF, according to data published in The American Journal of Cardiology.

Time-restricted eating interventions, especially those with an eating window of 8 hours or longer, are not associated with weight loss of 5% or greater for most adults with obesity, according to a speaker.

A novel bispecific GIP receptor antagonist and GLP-1 receptor agonist induced weight loss of up to 14.5% in adults with obesity with no safety concerns, according to data from a phase 1 trial.

Increased fat mass, particularly visceral adiposity, promotes kidney disease generation and progression through direct and indirect mechanisms, and pharmacologic treatment is necessary to avoid adverse outcomes, according to a speaker.

Women with higher levels of visceral adipose tissue are more likely to develop preeclampsia than those with less fat, according to findings from a Mendelian randomization published in The Journal of Clinical Endocrinology & Metabolism.

Adults with type 2 diabetes who use a GLP-1 receptor agonist for more than 1 year may have an increased risk for thyroid cancer, according to findings published in Diabetes Care.